HDFC Bank: Buy or sell? Brokerages maintain bullish view, see up to 18% upside on margin stability and long-term loan growth
Top brokerages remain bullish on HDFC Bank, reaffirming Buy ratings after the private lender reported a steady Q1FY26 performance. While net interest margins (NIM) compressed more than expected and slippages ticked up marginally, analysts point to strong provisioning, resilient core profitability, and a roadmap for loan growth revival as reasons to stay constructive on the stock. Nomura – Buy | Target: ₹2,190 | Upside: 12%
Nomura described the June quarter as a steady operating performance, with some softness on asset quality. However, the brokerage expects loan growth to pick up going forward, and sees the bank delivering RoA of 1.7–1.9% and RoE of 13–14.5% over FY26–28F. It values the core bank at 2.3x Jun-27F BVPS, maintaining a confident long-term view. Nuvama – Buy | Target: ₹2,270 | Upside: 16%
Nuvama highlighted a sharp 19 basis point QoQ drop in reported NIM, more than expected, but noted that core NIM declined only 11bps, reflecting underlying resilience. HDFC Bank reprices its EBLR (External Benchmark Linked Rate) loans faster than peers, affecting near-term margins.
The bank's asset quality remained best-in-class, with higher slippages primarily due to seasonal farm stress. Importantly, HDFC utilised nearly its entire ₹91 billion gain from HDB Financial Services for contingency and floating provisions, recognising just ₹8 billion as net gains—showcasing prudence in capital management. Core NII and PPOP were flat QoQ and up YoY, indicating operational stability. Bernstein – Buy | Target: ₹2,300 | Upside: 18%
Bernstein called it a good set of numbers, with headline EPS up 11% YoY. After adjusting for one-offs like the HDB stake sale, floating provisions, and tax credits, EPS growth stood at 7% YoY. Bernstein highlighted the loan-to-deposit ratio (LDR) falling to 95%, which positions the bank well to repair its balance sheet and resume healthy loan growth from FY27E. The brokerage continues to back HDFC Bank's long-term potential. Brokerage Summary: Brokerage Rating Target Price (₹) Upside from CMP (₹1,956) Bernstein Buy 2,300 +18% Nuvama Buy 2,270 +16% Nomura Buy 2,190 +12%
Despite near-term margin pressures, brokerages believe HDFC Bank's strong provisioning, capital discipline, and improving loan-to-deposit metrics will support sustainable growth over the next few years. All three firms remain firmly on the buy side, citing a favourable risk-reward at current levels.
Disclaimer: The brokerage views expressed are based on publicly available research reports and do not constitute investment advice. Readers should consult a certified financial advisor before making any investment decisions.
Ahmedabad Plane Crash
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Nomura reiterates buy on Infosys, sets Rs 1,880 target price after Australian carve-out deal with Telstra
By Markets Desk Published on August 14, 2025, 07:58 IST Nomura has reiterated its buy call on Infosys with a target price of ₹1,880 after the company announced a carve-out deal in Australia with Telstra. Under the agreement, Infosys will acquire a 75% stake and operational control in a newly created entity, while Telstra will retain the remaining 25%. The Indian IT major will pay AUD 233 million for its stake. Nomura estimates the acquisition will add around $70 million to Infosys' revenue in FY26, contributing approximately 35 basis points to overall growth. The brokerage views the deal as a strategic expansion of Infosys' capabilities and client reach in the Australian market, further strengthening its partnership with Telstra. The brokerage believes the move aligns with Infosys' focus on targeted acquisitions to drive geographic and sectoral growth, and with the company's solid balance sheet, it sees scope for further such transactions to enhance long-term earnings visibility. Disclaimer: The views and recommendations made in this article are those of Nomura. This article does not constitute investment advice. Investors should consult their financial advisors before making any investment decisions. Ahmedabad Plane Crash Markets Desk at
CNBC
8 hours ago
- CNBC
The consumer is under more pressure now, says Bernstein's Danilo Gargiulo
Danilo Gargiulo, Bernstein senior research analyst, joins 'Closing Bell: Overtime' to discuss what Cava's earnings mean for the fast-casual restaurant space and his read on the consumer.
Yahoo
8 hours ago
- Yahoo
Veteran analyst drops blunt 7-word take on AMD's China deal
Veteran analyst drops blunt 7-word take on AMD's China deal originally appeared on TheStreet. Bernstein's Stacy Rasgon isn't holding back on AMD's () new path to China's AI chip market. The tech giant struck an agreement with Washington, which effectively reopens sales of its high-end MI308 chips to Chinese customers. It does, however, come at a cost that's raising eyebrows on Wall Street. 💵💰💰💵 The change has the potential to do a lot of things, including shifting competitive dynamics, while setting a new tone for how U.S. chipmakers navigate future trade rules. Also, it opens up a Pandora's box on policy, precedent, and long-term strategy. For AMD, the stakes go beyond quarterly numbers, and Rasgon's pertinent take hints at broader industry consequences that could play out far beyond a single deal. Wall Street weighs pros and cons of U.S.-China AI chip deal The Trump administration struck what many would call an unusual agreement with China in a breakthrough for the AI chip market. The new deal allows Nvidia () and AMD to resume selling certain AI chips (Nvidia's H20 and AMD's MI308) in return, though, both giants need to pay 15% of those sales back to Washington. President Donald Trump had initially pushed for a 20% cut, with the revised stance showing that the approved chips don't compromise national security. Commerce has already begun issuing export licenses. The market reaction was mostly mixed. The bars see the arrangement as a 'pay-to-play' model, which sets a broader precedent for export-controlled sectors, likening it to an unofficial export tax. They warn it could significantly impede how businesses allocate capital and plan product strategies. Supporters, however, argue that gaining back access to the world's second-largest AI market outweighs the cost. Tight supply enables Nvidia to pass much of the 15% dent to customers, keeping margin erosion to a minimum while keeping China in its customer base. Nevertheless, the risks remain, especially if Beijing discourages approved chip purchases, undercutting demand. On top of that, legal and political hiccups over the constitutionality and long-term wisdom of the policy are also a possibility that can't be ignored. Bernstein's Stacy Rasgon: "Keeping 85% is better than zero percent" in AMD's China deal 'Keeping 85% is better than zero percent.' That's how Bernstein analyst Stacy Rasgon frames AMD's unique deal to resume AI chip sales in China, even if it entails giving up a sizeable revenue cut. As discussed earlier, the deal green-lights AMD's MI308 AI chip sales in China again after earlier export comes with a steep price tag, though: a hefty 15% of a sales cut that goes straight to Washington. Rasgon sees it mostly as a 'mixed bag.' On one hand, it gives AMD access to a rapidly growing market that's just too big to ignore. On the other hand, it could potentially slash 5 to 15 percentage points off gross margins for the affected products, potentially resulting in several hundred million dollars lost each year. Some of the hits could be passed along to consumers, but Rasgon warns that policy could be a big push for Chinese players like Huawei to supercharge their own AI chip development efforts. He also flagged a key tactical gap where Nvidia is designing export-compliant chips that could potentially avoid such fees, while AMD is yet to reveal any comparable China-specific products. For now, Rasgon is sticking with a Market Perform rating and $140 price target, which effectively reflects the current balancing act for investors. AMD posts record Q2 sales, eyes China as a second-half swing factor That said, it's imperative to recap AMD's mixed Q2 results, spurring investor sentiment in the process. It did post record revenue of $7.69 billion, up 32% from a year ago, while comfortably beating Wall Street estimates. However, its Non-GAAP EPS came in at $0.48, while GAAP EPS was $0.54. The culprit was roughly an $800 million inventory and related charges linked to U.S. export controls on its MI308 data-center GPU. Strip those charges away, and the non-GAAP gross margin would have been roughly 54% instead of 43%. More News: Tesla just got its biggest break yet in the robotaxi wars with a key permit Bank of America drops shocking price target on hot weight-loss stock post-earnings JPMorgan drops 3-word verdict on Amazon stock post-earnings Zeroing in on specific segments, Data Center sales came in at $3.2 billion, up 14% year over year. A big part of that was its strong EPYC CPU sales, which efficiently offset GPU headwinds in China. Client sales hit a stupendous $2.5 billion, up 67% on Ryzen demand. Similarly, Gaming rose 73% to $1.1 billion, while Embedded sales were a downer, slipping 4% to $824 million. These results took AMD's free cash flow to a whopping $1.18 billion. For Q3, its management guided to about $8.7 billion in sales (±$300 million) and a 54% non-GAAP gross margin, excluding any MI308 sales to China. Nevertheless, China is set to be the wild card for the rest of the year. With the export licenses approved, AMD can now offset part of the fee through pricing, resulting in a stronger Q3 showing. Hence, the bigger picture is clear, which shows that operational strength remains, but China policy will help define AMD's trajectory for the remainder of the analyst drops blunt 7-word take on AMD's China deal first appeared on TheStreet on Aug 12, 2025 This story was originally reported by TheStreet on Aug 12, 2025, where it first appeared. Sign in to access your portfolio
